| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Curriculum in Toxicology [E. J. M., J. A. S.] and Departments of Pathology and Laboratory Medicine [A-J. L. H., J. A. S.] and Environmental Sciences and Engineering [A. R., J. N., P. B. U., J. A. S.], University of North Carolina, Chapel Hill, North Carolina 27599-7431
Although the DNA adducts of vinyl chloride (VC) have been well characterized, previous studies have used single concentrations of VC that are well above contemporary human exposures. This study examined the exposure response to VC in male Sprague Dawley rats with respect to the molecular dose of the promutagenic DNA adduct N2,3-ethenoguanine (N2,3-
G). Adult rats were exposed by inhalation to 0, 10, 100, or 1100 ppm VC for 1 or 4 weeks (6 h/day, 5 days/week). Weanling rats were similarly exposed for 5 days. The amount of N2,3-
G in hepatocyte (HEP) and nonparenchymal cell (NPC) fractions obtained from the liver was measured with a sensitive immunoaffinity/gas chromatography/high-resolution mass spectrometry assay. Endogenous N2,3-
G was present in HEPs and NPCs from all unexposed rats. The exposure response to VC in each group and cell population was supralinear, with a linear increase from 0 to 100 ppm, and a plateau between 100 and 1100 ppm. There was no statistically significant difference in N2,3-
G concentrations between HEPs and NPCs in any adult exposure group, which suggests that factors other than adduct concentrations contribute to the particular susceptibility of NPCs to VC-induced carcinogenesis. The accumulation of N2,3-
G with respect to time was nearly linear in rats exposed to 600 ppm VC for 1, 2, 4, or 8 weeks (4 h/day, 5 days/week), and no repair of N2,3-
G was detected in rats exposed to VC for 4 weeks and allowed to recover for 1 week. N2,3-
G concentrations in HEPs from weanling rats were 23-fold greater than those in adult rats exposed for the same time. Higher adduct concentrations in young rats may contribute to their greater susceptibility to VC-induced hepatic angiosarcoma as well as their particular susceptibility to hepatocellular carcinoma. The molecular dosimetry of N2,3-
G in liver appears to be a sensitive and informative biomarker of genotoxic effect after exposure to VC. N2,3-
G was the predominant etheno adduct measured in vivo after exposure to VC, and the saturable nature of VC metabolism was reflected in its molecular dose. The relationships between endogenous N2,3-
G and that formed by low exposures to VC were demonstrated. Conclusions drawn from these exposures may be more relevant for risk assessment purposes than those drawn from high exposures where activation, detoxication, and repair pathways may be saturated or otherwise perturbed. These data are well suited for consideration in future risk assessments of VC that incorporate nontumor mode of action data.
This article has been cited by other articles:
![]() |
M. D. Stout, E. Bodes, R. Schoonhoven, P. B. Upton, G. S. Travlos, and J. A. Swenberg Toxicity, DNA Binding, and Cell Proliferation in Male F344 Rats following Short-term Gavage Exposures to Trans-2-Hexenal Toxicol Pathol, February 1, 2008; 36(2): 232 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Jeong, J. Nakamura, P. B. Upton, and J. A. Swenberg Pyrimido[1,2-a]-purin-10(3H)-one, M1G, is less prone to artifact than base oxidation Nucleic Acids Res., November 10, 2005; 33(19): 6426 - 6434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barbin, H. Ohgaki, J. Nakamura, M. Kurrer, P. Kleihues, and J. A. Swenberg Endogenous Deoxyribonucleic Acid (DNA) Damage in Human Tissues: A Comparison of Ethenobases with Aldehydic DNA Lesions Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1241 - 1247. [Abstract] [Full Text] |
||||
![]() |
E. J. Morinello, H. Koc, A. Ranasinghe, and J. A. Swenberg Differential Induction of N2,3-Ethenoguanine in Rat Brain and Liver after Exposure to Vinyl Chloride Cancer Res., September 15, 2002; 62(18): 5183 - 5188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |